Vaka 17

Özet

Primer santral sinir sistemi lenfoması, immün sistemi normal bireylerde bile görülebilen agresif bir non-Hodgkin B hücreli lenfoma alt tipidir. MRG’de derin yerleşimli, yoğun kontrastlanan ve belirgin difüzyon kısıtlılığı gösteren lezyonlar izlenir. Tedavide yüksek doz metotreksat temelli kemoterapi esastır.

Referanslar

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.doi:10.1182/blood-2016-01-643569

Green K, Munakomi S, Hogg JP. Central Nervous System Lymphoma. Current Diagnostic Pathology. 2024;3(1):45–52 PMID: 31424729

Jhaveri MD. Primary CNS lymphoma. Bennet NI (Ed). Diagnostic Imaging Brain.Philadelphia : Elsevier; 2021. p. 602–605.

Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiologica. 2009;50(2):217–225.doi: 10.1080/02841850802616752

Malikova H, Burghardtova M, Koubska E, et al. Secondary central nervous system lymphoma: spectrum of morphological MRI appearances. Neuropsychiatric Disease and Treatment. 2018;14:733–740.doi: 10.2147/NDT.S157959

Sayfalar

95-100

Yayınlanan

24 Aralık 2025

Lisans

Lisans